A meta-analysis of somatic KCNJ5 K+ channel mutations in 1636 patients with an aldosterone-producing adenoma

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 8, 2015, Pages E1089-E1095

  Lenzini, Livia ^a   Rossitto, Giacomo ^a   Maiolino, Giuseppe ^a   Letizia, Claudio ^b   Funder, John W ^c   Rossi, Gian Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL; ALDOSTERONE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; KCNJ5 PROTEIN, HUMAN;

ALDOSTERONE BLOOD LEVEL; ARTICLE; AUSTRALIA; BLOOD ANALYSIS; BLOOD PRESSURE; CHINA; CLINICAL FEATURE; EUROPE; GENE; GENETIC HETEROGENEITY; HUMAN; JAPAN; KCNJ5 POTASSIUM CHANNEL GENE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; OUTCOME ASSESSMENT; PHENOTYPE; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SEX DIFFERENCE; SOMATIC MUTATION; SYSTEMATIC REVIEW; TUMOR VOLUME; UNITED STATES; ADENOMA; ADRENAL CORTEX NEOPLASMS; ADULT; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETICS; HYPERALDOSTERONISM; MALE; META ANALYSIS; MIDDLE AGED; MUTATION; SECRETION (PROCESS); STATISTICS AND NUMERICAL DATA;

SCOPUS;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADULT; ALDOSTERONE; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; MUTATION;

EID: 84939132377     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-2149     Document Type: Article

References (27)

1. Rossi GP, Seccia TM, Pessina AC. A diagnostic algorithm-the holy grail of primary aldosteronism. Nat Rev Endocrinol. 2011;7(12):697-699.
2. Choi M, Scholl UI, Yue P, et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011;331(6018):768-772.
3. Rossitto G, Regolisti G, Rossi E, et al. Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma. Hypertension. 2013;61(2):526-533.
4. Kem DC, Li H, Velarde-Miranda C, et al. Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism. J Clin Endocrinol Metab. 2014;99(5):1790-1797.
5. Kuppusamy M, Caroccia B, Stindl J, et al. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium. J Clin Endocrinol Metab. 2014;99(9):E1765-E1773.
6. Cheng CJ, Sung CC, Wu ST, et al. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance. J Clin Endocrinol Metab. 2015:100(1):E155-E163.
7. Lenzini L, Rossi GP. The molecular basis of primary aldosteronism: From chimeric gene to channelopathy. Curr Opin Pharmacol. 2014;21C:35-42.
8. da Costa Santos CM, de Mattos Pimenta CA, Nobre MR. The PICO strategy for the research question construction and evidence search. Rev Lat Am Enfermagem. 2007;15(3):508-511.
9. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
10. Akerstrom T, Crona J, Delgado Verdugo A, et al. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS One. 2012;7(7):e41926.
11. Azizan EA, Murthy M, Stowasser M, et al. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas. Hypertension. 2012;59(3):587-591.
12. Boulkroun S, Beuschlein F, Rossi GP, et al. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension. 2012;59(3):592-598.
13. Fernandes-Rosa FL, Williams TA, Riester A, et al. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension. 2014;64(2):354-361.
14. Kitamoto T, Suematsu S, Matsuzawa Y, et al. Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas. J Atheroscler Thromb. 2015;22(2):191-200.
15. Taguchi R, Yamada M, Nakajima Y, et al. Expression and mutations of KCNJ5 mRNA in japanese patients with aldosterone-producing adenomas. J Clin Endocrinol Metab. 2012;97(4):1311-1319.
16. Williams TA, Monticone S, Schack VR, et al. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension. 2014;63(1):188-195.
17. Zheng FF, Zhu LM, Nie AF, et al. Clinical characteristics of somatic mutations in chinese patients with aldosterone-producing adenoma. Hypertension. 2015;65(3):622-628.
18. Arnesen T, Glomnes N, Stromsoy S, et al. Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from western Norway. Langenbecks Arch Surg. 2013;398(6):869-874.
19. Xekouki P, Hatch MM, Lin L, et al. KCNJ5 mutations in the national institutes of health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome. Endocr Relat Cancer. 2012;19(3):255-260.
20. Murthy M, Xu S, Massimo G, et al. Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism. Hypertension. 2014;63(4):783-789.
21. Beuschlein F, Boulkroun S, Osswald A, et al. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet. 2013 2013;45(4):440-444, 444e1-2.
22. Anderson CA, Appel LJ, Okuda N, et al. Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc. 2010;110(5):736-745.
23. Land MA, Webster J, Christoforou A, et al. Salt intake assessed by 24 h urinary sodium excretion in a random and opportunistic sample in Australia. BMJ Open. 2014;4(1):e003720-2013-003720.
24. Donfrancesco C, Ippolito R, Lo Noce C, et al. Excess dietary sodium and inadequate potassium intake in Italy: results of the MINISAL study. Nutr Metab Cardiovasc Dis. 2013;23(9):850-856.
25. Rossi GP, Bernini G, Caliumi C, et al PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293-2300.
26. Caroccia B, Seccia TM, Campos AG, et al. GPER-1 and estrogen receptor-beta ligands modulate aldosterone synthesis. Endocrinology. 2014;155(11):4296-4304.
27. Rossi GP, Cesari M, Letizia C, et al. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism. J Hypertens. 2014;32(7):1514-1521; discussion 1522.